Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.

MLA

Karlsson, Max J., et al. “Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.” Cancer Research, vol. 81, no. 9, May 2021, pp. 2545–55. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-20-2000.

APA

Karlsson, M. J., Costa Svedman, F., Tebani, A., Kotol, D., Höiom, V., Fagerberg, L., Edfors, F., Uhlén, M., Egyhazi Brage, S., & Maddalo, G. (2021). Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy. Cancer Research, 81(9), 2545–2555. https://doi.org/10.1158/0008-5472.CAN-20-2000

Chicago

Karlsson, Max J, Fernanda Costa Svedman, Abdellah Tebani, David Kotol, Veronica Höiom, Linn Fagerberg, Fredrik Edfors, Mathias Uhlén, Suzanne Egyhazi Brage, and Gianluca Maddalo. 2021. “Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.” Cancer Research 81 (9): 2545–55. doi:10.1158/0008-5472.CAN-20-2000.